Nachrichten zur Iovance Biotherapeutics Inc. Aktie

Is Iovance Biotherapeutics Stock a Buy Now?

Lets find out if this biotech can keep up its recent momentum.…

Iovance Biotherapeutics: Riding The Favorable Moment Could Bring Excellent Results

…

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics @themotleyfool #stocks $IOVA $CRSP

These companies are in the early days of their growth stories.…

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics

These companies are in the early days of their growth stories.…

Iovance Biotherapeutics: Initial Amtagvi Launch In Focus

…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

Piper Sandler lifts Iovance Biotherapeutics stock target to $19 By Investing.com

Piper Sandler lifts Iovance Biotherapeutics stock target to $19…

Iovance Biotherapeutics Stock Has 22% Upside, According to 1 Wall Street Analyst

With its first approval in hand, attention is now on the top line.…

Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer

SAN CARLOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company…

Could Iovance Biotherapeutics Stock Help You Become a Millionaire?

Does Iovance Biotherapeutics stock possess enough upside to generate life-changing returns for your portfolio?…

Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused…

Iovance Biotherapeutics, Inc. (IOVA) Q4 2023 Earnings Call Transcript

…

Is Iovance a Buy After Its First Regulatory Win?

Iovance Biotherapeutics has found a new way to treat cancer.…

Is Iovance a Buy After Its First Regulatory Win? @themotleyfool #stocks $IOVA

Iovance Biotherapeutics has found a new way to treat cancer.…

A Close Look At Iovance Biotherapeutics Accelerated Approval

…

Iovance Biotherapeutics price targets raised following FDA accelerated approval By Investing.com

Iovance Biotherapeutics price targets raised following FDA accelerated approval…

Why Iovance Biotherapeutics Stock Is Skyrocketing Today

…

Why Iovance Biotherapeutics Stock Is Skyrocketing Today

Iovance is no longer a clinical-stage biotech.…

Iovance Biotherapeutics: Amtagvis Pioneering Approval Sets New Standards In Melanoma

…

Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock

SAN CARLOS, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused…

3 Opportunities for Iovance Biotherapeutics Stock, and 1 Risk

The potential pitfall could be dire, but the odds seem to be in the biotechs favor.…

Is Iovance Biotherapeutics Stock a Buy Now?

It will take a while for its risks to resolve.…

Is Iovance Biotherapeutics Stock a Buy Now? @themotleyfool #stocks $IOVA

It will take a while for its risks to resolve.…

Whats Next for Iovance Biotherapeutics Stock?

Focusing on its clinical trial setback could mean missing the bigger picture.…

Whats Next for Iovance Biotherapeutics Stock? @themotleyfool #stocks $IOVA

Focusing on its clinical trial setback could mean missing the bigger picture.…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”),…

Iovance Biotherapeutics: Preparing For Volatility Around Lifileucels Upcoming PDUFA Date

…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

4 Best Breakout Stocks to Buy for Stellar Returns

Universal Stainless & Alloy Products (USAP), Lakeland Industries (LAKE), NGL Energy Partners (NGL) and Iovance Biotherapeutics (IOVA) have been selected…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Why Iovance Biotherapeutics Stock Popped Today

Iovance rebounded nicely after yesterdays drop, which came after the FDA put a clinical hold on its cancer-therapy trial.…

Why Iovance Biotherapeutics Stock Popped Today

…

Iovance Biotherapeutics faces setback as FDA imposes clinical hold on lung cancer trial

Iovance Biotherapeutics (NASDAQ:IOVA) shares plunged after it revealed that the FDA has imposed a clinical hold on its lung cancer…

Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer

SAN CARLOS, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused…

1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors

YONGIN, South Korea, December 14, 2023 – 1ST Biotherapeutics, Inc., a clinical-stage biotechnology company focused on the development of novel…

Iovance Biotherapeutics: The Easiest Money May Have Been Made, But Approval Does Seem Likely

…

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?

…

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? @themotleyfool #stocks $IOVA $LLY $^GSPC $PFE $NVO $AMGN $VKTX

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk…

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk…

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused…

Why Iovance Biotherapeutics Stock Is Marching Higher Today

Investors are excited by the prospects of a potential regulatory approval.…

Iovance Biotherapeutics, Inc. (IOVA) Q3 2023 Earnings Call Transcript

…

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023

SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused…

dpa-AFX ProFeed